Application of Advanced Statistical Tools to Achieve Continuous Analytical Verification: A Risk Assessment Case of the Impact of Analytical Method Performance on Process Performance Using a Bayesian Approach

  • Iris YanEmail author
  • Yijie Dong
Conference paper
Part of the Springer Proceedings in Mathematics & Statistics book series (PROMS, volume 218)


The criticalness of robust analytical performance is becoming more and more recognized in the pharmaceutical industry. An effective analytical control strategy needs to be defined, along with a process control strategy, to ensure that the measurement uncertainties are controlled to achieve the intended purposes of analytical methods. The principles of Continuous Process Verification (CPV) have been applied to the lifecycle management of analytical robustness, which leads to our vision of Continuous Analytical Verification (CAV) through a product lifecycle. This work proposes to apply advanced statistical tools to deliver on the vision of CAV. A Bayesian hierarchical modeling approach is a potential solution to integrate a risk-based control strategy into the framework of CAV from design, qualification, to continued verification. A case study is included to illustrate the benefits of a Bayesian-based systematic tool in assessing the impact of analytical performance on process performance and in informing decisions related to analytical control strategy, in order to ensure analytical and process robustness.


Continuous process verification Analytical control strategy Life cycle management Risk assessment 


  1. 1.
    US Department of Health and Human Services, Food and Drug Administration: Guidance for industry. Process validation: General principles and practices (2011)Google Scholar
  2. 2.
    Borman, P., Nethercote, P., Chatfield, M., Thompson, D., Truman, K.: The application of quality by design to analytical methods. Pharm. Technol. 31, 142–152 (2007)Google Scholar
  3. 3.
    Schweitzer, M., Pohl, M., Hanna-Brown, M., Nethercote, P., Borman, P., Hansen, G., Smith, K., Larew, J.: Implications and opportunities of applying QbD principles to analytical measurements. Pharm. Technol. 34(2), 52–59 (2010)Google Scholar
  4. 4.
    Borman, P., Popkin, M., Oxby, N., Chatfield, M., Elder, D.: Analytical methods and control strategies: the forgotten interface. Pharm. Outsourcing 16, 34–39 (2015)Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Global Statistics, Bristol-Myers Squibb Co.New BrunswickUSA

Personalised recommendations